MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/cancers13215480

Медицинская библиотека · Cancers · 2021

Nano-Based Drug Delivery and Targeting to Overcome Drug Resistance of Ovarian Cancers.

McFadden Melayshia, Singh Santosh Kumar, Oprea-Ilies Gabriela, Singh Rajesh

СтатьяОбзорПеревод в очереди

Аннотация

Ovarian cancer (OvCa) is a destructive malignancy due to difficulties in early detection and late advanced-stage diagnoses, leading to high morbidity and mortality rates for women. Currently, the quality treatment for OvCa includes tumor debulking surgery and intravenous platinum-based chemotherapy. However, numerous patients either succumb to the disease or undergo relapse due to drug resistance, such as to platinum drugs. There are several mechanisms that cause cancer cells' resistance to chemotherapy, such as inactivation of the drug, alteration of the drug targets, enhancement of DNA repair of drug-induced damage, and multidrug resistance (MDR). Some targeted therapies, such as nanoparticles, and some non-targeted therapies, such as natural products, reverse MDR. Nanoparticle targeting can lead to the reversal of MDR by allowing direct access for agents to specific tumor sites. Natural products have many anti-cancer properties that adversely regulate the factors contributing to MDR. The present review displays the current problems in OvCa treatments that lead to resistance and proposes using nanotechnology and natural products to overcome drug resistance.

Для цитирования: McFadden Melayshia, Singh Santosh Kumar, Oprea-Ilies Gabriela, Singh Rajesh. Nano-Based Drug Delivery and Targeting to Overcome Drug Resistance of Ovarian Cancers.. Cancers. 2021. DOI: 10.3390/cancers13215480.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.